X-PLENDED TAB
X-PLENDED TAB (Rosuvastatin 5,10 & 20 mg Tab)
- Moderate Intensity Statin
- A Better Option
- Superior Efficacy Even With lower Dose
INDICATIONS
Hyperlipidemia and Mixed Dyslipidemia
X-PLENDED is indicated as adjunctive therapy to diet to reduce elevated Total-C,
LDL-C, ApoB, non HDL-C, and triglycerides and to increase HDL-C in adult patients
with primary hyperlipidemia or mixed dyslipidemia.
Pediatric Patients 8 to 17 years of age with Heterozygous Familial Hypercholesterolemia (HeFH)
Adjunct to diet to reduce Total-C, LDL-C and ApoB levels in children and adolescents
8-17 years of age with heterozygous familial hypercholesterolemia if after an adequate
trial of diet therapy the following findings are present: LDL-C > 190 mg/dL or > 160
mg/dL and there is a positive family history of premature cardiovascular disease (CVD) or
two or more other CVD risk factors
Pediatric Patients 7 to 17 years of age with Homozygous Familial Hypercholesterolemia
Reduce LDL-C, Total-C, non HDL-C and ApoB in children and adolescents 7 to 17 years
of age with homozygous familial hypercholesterolemia, either alone or with other
lipid-lowering treatments (e.g., LDL apheresis).
Hypertriglyceridemia
X-PLENDED (Rosuvastatin) is indicated as adjunctive therapy to diet for the treatment of
adult patients with hypertriglyceridemia.
Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia)
X-PLENDED is indicated as an adjunct to diet for the treatment of patients with primary
dysbetalipoproteinemia (Type III Hyperlipoproteinemia).
Homozygous Familial Hypercholesterolemia
X-PLENDED is indicated as adjunctive therapy to other lipid-lowering treatments (e.g.,
LDL apheresis) or alone if such treatments are unavailable to reduce LDL-C, Total-C, and
ApoB in adult patients with homozygous familial hypercholesterolemia
